Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jeffrey John Popma, M.D.

Co-Author

This page shows the publications co-authored by Jeffrey Popma and Robert Yeh.
Connection Strength

3.265
  1. Long-term outcomes of percutaneous coronary intervention for in-stent restenosis among Medicare beneficiaries. EuroIntervention. 2021 Aug 06; 17(5):e380-e387.
    View in: PubMed
    Score: 0.238
  2. Validation of Administrative Claims to Ascertain Outcomes in Pivotal Trials of Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2020 08 10; 13(15):1777-1785.
    View in: PubMed
    Score: 0.221
  3. Use of Administrative Claims to Assess Outcomes and Treatment Effect in Randomized Clinical Trials for Transcatheter Aortic Valve Replacement: Findings From the EXTEND Study. Circulation. 2020 07 21; 142(3):203-213.
    View in: PubMed
    Score: 0.219
  4. Comparison of Clinical Trials and Administrative Claims to Identify Stroke Among Patients Undergoing Aortic Valve Replacement: Findings From the EXTEND Study. Circ Cardiovasc Interv. 2019 11; 12(11):e008231.
    View in: PubMed
    Score: 0.211
  5. Geographic Patterns of Growth for Transcatheter Aortic Valve Replacement in the United States. Circulation. 2019 09 10; 140(11):969-971.
    View in: PubMed
    Score: 0.208
  6. Frailty and related outcomes in patients undergoing transcatheter valve therapies in a nationwide cohort. Eur Heart J. 2019 07 14; 40(27):2231-2239.
    View in: PubMed
    Score: 0.206
  7. Trends in isolated aortic valve replacement in the United States in the early phase of expansion of TAVR. Int J Cardiol. 2019 10 01; 292:68-72.
    View in: PubMed
    Score: 0.205
  8. Validating the use of registries and claims data to support randomized trials: Rationale and design of the Extending Trial-Based Evaluations of Medical Therapies Using Novel Sources of Data (EXTEND) Study. Am Heart J. 2019 06; 212:64-71.
    View in: PubMed
    Score: 0.201
  9. Hospital Variation in the Utilization of Short-Term Nondurable Mechanical Circulatory Support in Myocardial Infarction Complicated by Cardiogenic Shock. Circ Cardiovasc Interv. 2019 01; 12(1):e007270.
    View in: PubMed
    Score: 0.199
  10. Association of Hospital Surgical Aortic Valve Replacement Quality With 30-Day and 1-Year Mortality After Transcatheter Aortic Valve Replacement. JAMA Cardiol. 2019 01 01; 4(1):16-22.
    View in: PubMed
    Score: 0.199
  11. Trends in Isolated Surgical Aortic Valve Replacement According to Hospital-Based Transcatheter Aortic Valve Replacement Volumes. JACC Cardiovasc Interv. 2018 11 12; 11(21):2148-2156.
    View in: PubMed
    Score: 0.196
  12. The Value of Claims-Based Nontraditional Risk Factors in Predicting Long-term Mortality After MitraClip Procedure. Can J Cardiol. 2018 12; 34(12):1648-1654.
    View in: PubMed
    Score: 0.196
  13. Impact of a Claims-Based Frailty Indicator on the Prediction of Long-Term Mortality After Transcatheter Aortic Valve Replacement in Medicare Beneficiaries. Circ Cardiovasc Qual Outcomes. 2018 10; 11(10):e005048.
    View in: PubMed
    Score: 0.195
  14. Prevalence and Outcomes of Isolated Tricuspid Valve Surgery Among Medicare Beneficiaries. Am J Cardiol. 2019 01 01; 123(1):132-138.
    View in: PubMed
    Score: 0.195
  15. National trends, predictors of use, and in-hospital outcomes in mechanical circulatory support for cardiogenic shock. EuroIntervention. 2018 04 06; 13(18):e2152-e2159.
    View in: PubMed
    Score: 0.189
  16. Utilization, In-Hospital Mortality, and 30-Day Readmission After Percutaneous Mitral Valve Repair in the United States Shortly After Device Approval. Am J Cardiol. 2018 06 01; 121(11):1365-1372.
    View in: PubMed
    Score: 0.187
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.